SBL
HUM icon

Sargent Bickham Lagudis’s Humana HUM Stock Holding History

Sargent Bickham Lagudis’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20
Closed -$9K – 1053
2022
Q2 		$9K Buy
+20
New +$8.9K ﹤0.01% 711
2017
Q1 		– Sell
-60
Closed -$12K – 763
2016
Q4 		$12K Hold
60
– – ﹤0.01% 535
2016
Q3 		$11K Hold
60
– – ﹤0.01% 557
2016
Q2 		$11K Hold
60
– – ﹤0.01% 530
2016
Q1 		$11K Buy
+60
New +$10.4K ﹤0.01% 555

Other funds holding HUM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sargent Bickham Lagudis's HUM Position: Q3 2022 in Review

Sargent Bickham Lagudis sold out of Humana (HUM) in Q3 2022, closing a stake of 20 shares — an estimated $9K sold.

Sargent Bickham Lagudis first reported a position in HUM in Q1 2016 and held it in 5 quarters. The position peaked at $12K in Q4 2016. 1,001 funds tracked by Wall St. Rank hold HUM as of Q3 2022.

  • Sargent Bickham Lagudis reported no remaining Humana position as of Q3 2022 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 20 Humana shares in Q3 2022, an estimated $9K.
  • Sargent Bickham Lagudis first reported a position in Humana in Q1 2016 and held it in 5 quarters.
  • Sargent Bickham Lagudis's Humana position peaked at $12K in Q4 2016.
  • 1,001 funds tracked by Wall St. Rank held Humana as of Q3 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2022, filed 27 Oct 2022.